Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: J Oral Pathol Med. 2012 Jun 9;42(1):53–60. doi: 10.1111/j.1600-0714.2012.01183.x

Table 3.

Effects of HIV infection and long-term use of ART on the expression of hBD2 mRNA and its salivary protein levels based on logistic regression

hBD2 Adjusted odd ratios (95% Confidence Interval)
HIV-positive (HIV-negative as reference) Short-term ART (No-ART as reference) Long-term ART (No-ART as reference)
Expression of hBD2 mRNA in buccal mucosa >5 0.48 (0.19, 1.20) 0.77 (0.34, 1.77) 1.37 (0.61, 3.10)
Salivary levels of hBD2 protein
 - Unstimulated saliva >50 6.02 (2.69, 13.46) 0.84 (0.32, 2.19) 1.19 (0.46, 3.09)
 - Stimulated saliva >100 0.87 (0.39, 1.95) 0.69 (0.29, 1.67) 1.44 (0.60, 3.47)